Digestive Diseases and Sciences

, Volume 42, Issue 7, pp 1421–1427 | Cite as

Depression in Patients with Cirrhosis (Impact on Outcome)

  • Nina Singh
  • Timothy Gayowski
  • Marilyn M. Wagener
  • Ignazio R. Marino


The impact of depression (assessed by the BeckDepression Inventory) on quality of life and outcome wasprospectively assessed in adult patients with cirrhosis.Patients with depression had significantly poorer perceived quality of life (P = 0.006),poorer adaptive coping (P = 0.001), and lower functionalstatus, ie, Karnofsky performance score (P = 0.06), ascompared to the nondepressed patients. Survival after transplantation was not different betweendepressed and nondepressed patients. However, thepatients with depression were significantly more likelyto die while awaiting transplantation than thenondepressed patients (P = 0.02). The difference inmortality between the depressed and the nondepressedpatients with end-stage liver disease could not beexplained by the severity of illness variables;Child-Pugh score, complications of liver disease, renal function,serum albumin, prothrombin time, frequency and durationof hospitalizations were not significantly different fordepressed and nondepressed patients. Symptoms of depression should be sought in patients withcirrhosis since depression is a modifiable illness thatis amenable to treatment.



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wells KB, Stewart A, Hays RD, Burnam A, Rogers W, Daniels M, Berry S, Greenfeld S, Ware J: The functioning and well-being of depressed patients. Results from the medical outcomes study. JAMA 262:914–919, 1989Google Scholar
  2. 2.
    Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction, impact on 6-month survival. JAMA 270:1819–1825, 1993Google Scholar
  3. 3.
    Ahern DK, Gorkin L, Anderson JL, et al: Biobehavioral variables and mortality or cardiac arrest in the cardiac arrhythmia pilot study. Am J Cardiol 66:59–62, 1990Google Scholar
  4. 4.
    Roose SP, Alack GW, Woodrings: Death, depression, and heart disease. J Clin Psychiatry 52(suppl):34–39, 1991Google Scholar
  5. 5.
    Shekelle RB, Raynor WJ, Ostfeld A, et al: Psychological depression and 17 year risk of death from cancer. Psychosom Med 43:117–125, 1981Google Scholar
  6. 6.
    Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R, Kostis J, Pressel S, Schron E: Change in depression as a precursor of cardiovascular events. Arch Intern Med 156:553–561, 1996Google Scholar
  7. 7.
    Rodriguz JR, Davis GL, Howard RJ, Brunson ME, Langham MR, Haiman S: Psychological adjustment of liver transplant candidates. Clin 7:227–229, 1993Google Scholar
  8. 8.
    Bonsel GJ, Essink-Bot ML, Klompmaker IJ, Slooff MJH: Assessment of the quality of life before and following transplantation. Transplantation 53:796–800, 1992Google Scholar
  9. 9.
    Beck AT, Ward CH, Mendelson M: An inventory for measuring depression. Arch Gen Psychiatry 6:561–571, 1961Google Scholar
  10. 10.
    Perry S, Fishman B, Jacobberg L, Frances A: Relationship over one year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry 49:396–401, 1992Google Scholar
  11. 11.
    Perez-Stable EJ, Miranda J, Munoz RF, Ying YW: Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Intern Med 150:1083–1088, 1990Google Scholar
  12. 12.
    Mulrow CD, Williams JW, Gerety MB, Ramirez G, Montiel OM, Kerber C: Case-finding instruments in depression in primary care settings. Ann Intern Med 122:913–921, 1995Google Scholar
  13. 13.
    Namir S, Wolcott DL, Fawzy FI, et al: Coping with AIDS: Psychological and health implications. Appl Soc Psychiatry 17:309–328, 1987Google Scholar
  14. 14.
    Singh N, Squier C, Sivek C, Wagener MM, Nguyen MH, Goetz A, Yu VL: Determinants of compliance in patients with human immunodeficiency syndrome: Prospective assessment with implications for enhancing compliance. AIDS Care 8:261–269, 1996Google Scholar
  15. 15.
    Grieco A, Long CJ: Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychol 3:129–142, 1984Google Scholar
  16. 16.
    Sherlock S, Dooley J: Hepatic cirrhosis. In Diseases of the Liver and Biliary System, 9th ed. S Sherlock, J Dooley (eds). London, Blackwell Scientific Publications 1993, pp 357–369Google Scholar
  17. 17.
    Ruberman W, Weinblatt E, Goldberg JD, Chaudhry BS: Psychosocial influences or mortality after myocardial infarction. N Engl J Med 311:552–559, 1984Google Scholar
  18. 18.
    Case RB, Moss J, Case N, et al: Living alone after myocardial infarction: Impact on prognosis. JAMA 267:515–519, 1992Google Scholar
  19. 19.
    Haga DA, Dyck MJ, Ernst D: Empirical status of cognitive theory of depression. Psychol Bull 110:215–236, 1991Google Scholar
  20. 20.
    Lorr M, Daston P, Smith IR: An analysis of mood states. Educ Psychol Meas 27:89–96, 1967Google Scholar
  21. 21.
    Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z: Mood disorder and multiple sclerosis. Arch Neurol 44:376–378, 1987Google Scholar
  22. 22.
    Black DW, Warrack G, Winokur G: Excess mortality among psychiatric patients. The Iowa record-linkage study. JAMA 253:58–61, 1985Google Scholar
  23. 23.
    Irwin M, Daniels M, Bloom ET, Smith TL, Weiner H: Life events, depressive symptoms and immune function. Am J Psychiatry 144:437–441, 1987Google Scholar
  24. 24.
    Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R: Depressed lymphocyte function after bereavement. Lancet 1:834–836, 1977Google Scholar
  25. 25.
    Landmann RM, Muller FB, Perini C, et al: Changes of immunoregulatory cells induced by psychological and physical stress: Relationship to plasma catecholamines. Clin Exp Immunol 58:127–135, 1984Google Scholar
  26. 26.
    Keller SE, Schleifer SJ, Liota AS, et al: Stress induced alterations of immunity in hypophysectomized rats. Proc Natl Acad Sci USA 85:9297–9301, 1988Google Scholar
  27. 27.
    Koff WC, Fann AV, Dunegan MA, et al: Caltecholamine-induced suppression of interleukin 1 production. Lymphokine Res 5:239–247, 1986Google Scholar
  28. 28.
    Vanhoutte PM: Platelet-derived serotonin, the endothelium and cardiovascular disease. J Cardiovasc Pharmacol 17(suppl 5):6–12, 1991Google Scholar
  29. 29.
    Meltzer HY, Arora RC: Platelet serotonin studies in affective disorders: Evidence for a serotonin abnormality? In W Sandler, A Doppen, S Harnett (eds). 5-Hydroxytryptamine in Psychiatry. Oxford, Oxford University Press, 1991, pp 50–89Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Nina Singh
  • Timothy Gayowski
  • Marilyn M. Wagener
  • Ignazio R. Marino

There are no affiliations available

Personalised recommendations